---
title: "景顺投资管理有限公司：表格 8.3 - 英杰华 (ADR)；公开交易披露"
description: "景顺投资管理有限公司：第 8.3 号表格 - 英杰华 (ADR)；公开交易披露"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/221795459.md"
published_at: "2024-12-09T11:06:51.000Z"
---

# 景顺投资管理有限公司：表格 8.3 - 英杰华 (ADR)；公开交易披露

> 景顺投资管理有限公司：第 8.3 号表格 - 英杰华 (ADR)；公开交易披露

**PUBLIC DEALING DISCLOSURE** **BY**  
**A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE**  
**Rule 8.3 of the Takeover Code (the “Code”)**

**1.****KEY INFORMATION** **(a)****Full name of discloser:**Invesco Ltd. **(b)****Owner or controller of interests and short positions disclosed, if different from 1(a):**  
*The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.* **(c)****Name of offeror/offeree in relation to whose relevant securities this form relates:**  
*Use a separate form for each offeror/offeree*Aviva PLC **(d)****If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:** **(e)****Date position held/dealing undertaken:**  
*For an opening position disclosure, state the latest practicable date prior to the disclosure*06.12.2024 **(f)****In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?**  
*If it is a cash offer or possible cash offer, state “N/A”*Yes, Direct Line Insurance Group PLC **2.****POSITIONS OF THE PERSON MAKING THE DISCLOSURE** *If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.* **(a)****Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)** **Class of relevant security:****32 17/19p ordinary** **GB00BPQY8M80 & ADR US05382A3023** **Interests****Short Positions** **Number****%****Number****%** **(1)****Relevant securities owned and/or controlled:**44,620,2551.66 **(2)****Cash-settled derivatives:** **(3)****Stock-settled derivatives (including options) and agreements to purchase/sell:** **Total**44,620,2551.66 *All interests and all short positions should be disclosed.*

*Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).*

**(b)****Rights to subscribe for new securities (including directors’ and other employee options)** **Class of relevant security in relation to which subscription right exists:** **Details, including nature of the rights concerned and relevant percentages:** **3.****DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE** *Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.*

*The currency of all prices and other monetary amounts should be stated.*

**(a)****Purchases and sales** **Class of relevant security****Purchase/sale****Number of securities****Price per unit** 32 17/19p ordinary GB00BPQY8M80Purchase2,9314.84 GBP 32 17/19p ordinary GB00BPQY8M80Purchase1,4374.88 GBP 32 17/19p ordinary GB00BPQY8M80Sale3184.84 GBP **(b)****Cash-settled derivative transactions** **Class of relevant security****Product description** *e.g. CFD***Nature of dealing** *e.g. opening/closing a long/short position, increasing/reducing a long/short position***Number of reference securities****Price per unit** **(c)****Stock-settled derivative transactions (including options)** **(i)****Writing, selling, purchasing or varying** **Class of relevant security****Product description** *e.g. call option***Writing, purchasing, selling, varying etc.****Number of securities to which option relates****Exercise price per unit****Type** *e.g. American, European etc.***Expiry date****Option money paid/ received per unit** **(ii)****Exercise** **Class of relevant security****Product description** *e.g. call option***Exercising/ exercised against****Number of securities****Exercise price per unit** **(d)****Other dealings (including subscribing for new securities)** **Class of relevant security****Nature of dealing** *e.g. subscription, conversion***Details****Price per unit (if applicable)** **4.****OTHER INFORMATION** **(a)****Indemnity and other dealing arrangements** **Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:**  
*Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”* None **(b)****Agreements, arrangements, or understandings relating to options or derivatives** **Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:**  
**(i) the voting rights of any relevant securities under any option; or**  
**(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:**  
*If there are no such agreements, arrangements or understandings, state “none”* None **Is a Supplemental Form 8 (Open Positions) attached?**NO **Date of disclosure**09.12.2024 **Contact name**Philippa Holmes **Telephone number**+441491417447

*Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.*

*The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0) 20 7638 0129.*

*The Code can be viewed on the Panel’s website at* *www.thetakeoverpanel.org.uk**.*

### Related Stocks

- [IVZ.US - 景顺投资管理](https://longbridge.com/zh-CN/quote/IVZ.US.md)
- [AVVIY.US - 英杰华(ADR)](https://longbridge.com/zh-CN/quote/AVVIY.US.md)
- [FORM.US - Formfactor](https://longbridge.com/zh-CN/quote/FORM.US.md)
- [AV.UK - 英杰华集团](https://longbridge.com/zh-CN/quote/AV.UK.md)
- [IP.US - International Paper](https://longbridge.com/zh-CN/quote/IP.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| REG - Invesco II 美國國債 10 年以上 - 淨資產價值 | 景順美國國債 10 年以上 UCITS ETF 截至 2026 年 2 月 17 日報告的淨資產值（NAV）為 11,706,123.37 美元，每股淨資產值為 4.948 美元。該基金髮行了 2,365,787 股，此信息由倫敦證券交易所 | [Link](https://longbridge.com/zh-CN/news/276212812.md) |
| REG - 景順工業標準普爾 - 淨資產價值 | 景順投資管理工業類 S&P 美國精選行業 UCITS ETF 截至 2026 年 2 月 19 日報告每股淨資產值（NAV）為 974.4006 美元，發行總股數為 148,711 股。該信息由倫敦證券交易所的新聞服務 RNS 提供，經過金 | [Link](https://longbridge.com/zh-CN/news/276431698.md) |
| REG - IVZ II 2030 USD A $ - 淨資產價值 | 景順投資管理 BulletShares 2030 美元企業債券 UCITS ETF 報告的淨資產值（NAV）為 27,616,705.90 美元，每股淨資產值為 5.557 美元。該基金已發行 4,969,469 股，相關信息由倫敦證券交易 | [Link](https://longbridge.com/zh-CN/news/276211122.md) |
| REG - IVZ HealthS&PUS - 淨資產值 | 景順醫療保健 S&P 美國精選行業 UCITS ETF 截至 2026 年 2 月 19 日報告每股淨資產值（NAV）為 774.9254 美元，發行總股數為 527,565 股。該信息由倫敦證券交易所的新聞服務 RNS 提供，經過金融行為 | [Link](https://longbridge.com/zh-CN/news/276431715.md) |
| REG - IVZ II 2029 USD D $ - 淨資產值 | 景順投資管理 2029 年美元企業債券 UCITS ETF 報告的淨資產值（NAV）為 3,905,773.51 美元，每股淨資產值為 5.365 美元。發行的股份總數為 728,008，相關信息由倫敦證券交易所的新聞服務 RNS 提供，該 | [Link](https://longbridge.com/zh-CN/news/276211103.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。
